Skip to main content
Erschienen in:

26.11.2021 | Original Paper

Predictors of subsequent primary melanoma: a case–control study

verfasst von: Francesco Bellinato, Paolo Rosina, Beatrice Tonin, Paolo Gisondi, Giampiero Girolomoni

Erschienen in: Archives of Dermatological Research | Ausgabe 9/2022

Einloggen, um Zugang zu erhalten

Abstract

Patients with history of malignant melanoma (MM) are at risk of developing subsequent primary MM (SPM). Predictors of SPM may be helpful to identify patients at higher risk. The objective of the study is to investigate the phenotypic traits, indirect actinic exposure features and pathological variables associated with the risk of development of SPM. A ten-year retrospective case–control study was undertaken involving patients following MM excision who underwent regular video-dermoscopic examination at 4—6-month intervals for the first 5 years, followed by annual dermoscopic examination for the following five years. Patients with only one primary cutaneous MM were compared with those who developed at least one SPM. A total of 577 patients were included, 309 (53.6%) men and 268 (46.5%) women (mean age, 55 ± 15 years), comprising 450 patients with single melanoma and 127 with at least one SPM. The median time span to the SPM was 30 (IQR 12–53) months. Compared to the first melanoma, SPM were thinner, mean Breslow 0.56 ± 0.64 mm vs 1.37 ± 1.83 mm (p < 0.001); in situ MM prevalence 12% vs 36% (p < 0.001). 36 % of the patients with SPM developed it in the anatomical site of the previous melanoma. At multivariate analysis, having numerous naevi (i.e. 10–50 nevi) OR = 2.88 (95% CI 1.32–6.28, previous dysplastic naevi excisions OR = 2.51 (95% CI 1.53–4.12), solar lentigo OR = 2.68 (95% CI 1.67–4.31) and actinic keratosis OR = 3.09 (95% CI 1.64–4.31) were associated with an increased risk of SPM. These features may identify persons at increased risk of developing SPM.
Literatur
1.
Zurück zum Zitat Welch HG, Mazer BL, Adamson AS (2021) The rapid rise in cutaneous melanoma diagnoses. N Engl J Med 384:72–79CrossRef Welch HG, Mazer BL, Adamson AS (2021) The rapid rise in cutaneous melanoma diagnoses. N Engl J Med 384:72–79CrossRef
2.
Zurück zum Zitat Pflugfelder A, Kochs C, Blum A et al (2013) German Dermatological Society; Dermatologic Cooperative Oncology Group. Malignant melanoma S3-guideline “diagnosis, therapy and follow-up of melanoma.” J Dtsch Dermatol Ges 11:1–126PubMed Pflugfelder A, Kochs C, Blum A et al (2013) German Dermatological Society; Dermatologic Cooperative Oncology Group. Malignant melanoma S3-guideline “diagnosis, therapy and follow-up of melanoma.” J Dtsch Dermatol Ges 11:1–126PubMed
3.
Zurück zum Zitat Bichakjian CK, Halpern AC, Johnson TM et al (2011) American Academy of Dermatology. Guidelines of care for the management of primary cutaneous melanoma. J Am Acad Dermatol 65:1032–1047CrossRef Bichakjian CK, Halpern AC, Johnson TM et al (2011) American Academy of Dermatology. Guidelines of care for the management of primary cutaneous melanoma. J Am Acad Dermatol 65:1032–1047CrossRef
4.
Zurück zum Zitat Johnson TM, Hamilton T, Lowe L (1998) Multiple primary melanomas. J Am Acad Dermatol 39:422–427CrossRef Johnson TM, Hamilton T, Lowe L (1998) Multiple primary melanomas. J Am Acad Dermatol 39:422–427CrossRef
5.
Zurück zum Zitat DiFronzo LA, Wanek LA, Morton DL (2001) Earlier diagnosis of second primary melanoma confirms the benefits of patient education and routine postoperative follow-up. Cancer 91:1520–1524CrossRef DiFronzo LA, Wanek LA, Morton DL (2001) Earlier diagnosis of second primary melanoma confirms the benefits of patient education and routine postoperative follow-up. Cancer 91:1520–1524CrossRef
6.
Zurück zum Zitat Youlden DR, Baade PD, Soyer HP, Youl PH, Kimlin MG, Aitken JF, Green AC, Khosrotehrani K (2016) Ten-year survival after multiple invasive melanomas is worse than after a single melanoma: a population-based study. J Invest Dermatol 136:2270–2276CrossRef Youlden DR, Baade PD, Soyer HP, Youl PH, Kimlin MG, Aitken JF, Green AC, Khosrotehrani K (2016) Ten-year survival after multiple invasive melanomas is worse than after a single melanoma: a population-based study. J Invest Dermatol 136:2270–2276CrossRef
7.
Zurück zum Zitat Bradford PT, Freedman DM, Goldstein AM, Tucker MA (2010) Increased risk of second primary cancers after a diagnosis of melanoma. Arch Dermatol 146:265–272CrossRef Bradford PT, Freedman DM, Goldstein AM, Tucker MA (2010) Increased risk of second primary cancers after a diagnosis of melanoma. Arch Dermatol 146:265–272CrossRef
8.
Zurück zum Zitat Siskind V, Hughes MC, Palmer JM, Symmons JM, Aitken JF, Martin NG et al (2011) Nevi, family history, and fair skin increase the risk of second primary melanoma. J Invest Dermatol 131:461–467CrossRef Siskind V, Hughes MC, Palmer JM, Symmons JM, Aitken JF, Martin NG et al (2011) Nevi, family history, and fair skin increase the risk of second primary melanoma. J Invest Dermatol 131:461–467CrossRef
9.
Zurück zum Zitat Bower MR, Scoggins CR, Martin RC 2nd, Mays MP, Edwards MJ, Reintgen DS, Ross MI, Urist MM, Noyes RD, Sussman JJ, Hagendoorn LJ, Stromberg AJ, McMasters K (2010) Second primary melanomas: incidence and outcome. Am Surg 76:675–681CrossRef Bower MR, Scoggins CR, Martin RC 2nd, Mays MP, Edwards MJ, Reintgen DS, Ross MI, Urist MM, Noyes RD, Sussman JJ, Hagendoorn LJ, Stromberg AJ, McMasters K (2010) Second primary melanomas: incidence and outcome. Am Surg 76:675–681CrossRef
10.
Zurück zum Zitat Hwa C, Price LS, Belitskaya-Levy I, Ma MW, Shapiro RL, Berman RS et al (2012) Single versus multiple primary melanomas: old questions and new answers. Cancer 118:4184–4192CrossRef Hwa C, Price LS, Belitskaya-Levy I, Ma MW, Shapiro RL, Berman RS et al (2012) Single versus multiple primary melanomas: old questions and new answers. Cancer 118:4184–4192CrossRef
11.
Zurück zum Zitat Jones MS, Torisu-Itakura H, Flaherty DC, Schoellhammer HF, Lee J, Sim MS et al (2016) Second primary melanoma: risk factors, histopathologic features, survival, and implications for follow-up. Am Surg 82:1009–1013CrossRef Jones MS, Torisu-Itakura H, Flaherty DC, Schoellhammer HF, Lee J, Sim MS et al (2016) Second primary melanoma: risk factors, histopathologic features, survival, and implications for follow-up. Am Surg 82:1009–1013CrossRef
12.
Zurück zum Zitat Cameron MC, Lee E, Hibler BP, Barker CA, Mori S, Cordova M, Nehal KS, Rossi AM (2019) Basal cell carcinoma: epidemiology; pathophysiology; clinical and histological subtypes; and disease associations. J Am Acad Dermatol 80:303–317 (J Am Acad Dermatol 2021 85 535)CrossRef Cameron MC, Lee E, Hibler BP, Barker CA, Mori S, Cordova M, Nehal KS, Rossi AM (2019) Basal cell carcinoma: epidemiology; pathophysiology; clinical and histological subtypes; and disease associations. J Am Acad Dermatol 80:303–317 (J Am Acad Dermatol 2021 85 535)CrossRef
13.
Zurück zum Zitat Giles G, Staples M, McCredie M, Coates M (1995) Multiple primary melanomas: an analysis of cancer registry data from Victoria and New South Wales. Melanoma Res 5:433–438CrossRef Giles G, Staples M, McCredie M, Coates M (1995) Multiple primary melanomas: an analysis of cancer registry data from Victoria and New South Wales. Melanoma Res 5:433–438CrossRef
14.
Zurück zum Zitat Moore MM, Geller AC, Warton EM, Schwalbe J, Asgari MM (2015) Multiple primary melanomas among 16,570 patients with melanoma diagnosed at Kaiser Permanente Northern California, 1996 to 2011. J Am Acad Dermatol 73:630–636CrossRef Moore MM, Geller AC, Warton EM, Schwalbe J, Asgari MM (2015) Multiple primary melanomas among 16,570 patients with melanoma diagnosed at Kaiser Permanente Northern California, 1996 to 2011. J Am Acad Dermatol 73:630–636CrossRef
15.
Zurück zum Zitat Stam-Posthuma JJ, van Duinen C, Scheffer E, Vink J, Bergman W (2001) Multiple primary melanomas. J Am Acad Dermatol 44:22–27CrossRef Stam-Posthuma JJ, van Duinen C, Scheffer E, Vink J, Bergman W (2001) Multiple primary melanomas. J Am Acad Dermatol 44:22–27CrossRef
16.
Zurück zum Zitat Krajewski AC, Hart DR, Hieken TJ (2016) Multiple primary melanoma in the elderly. Am J Surg 211:84–88CrossRef Krajewski AC, Hart DR, Hieken TJ (2016) Multiple primary melanoma in the elderly. Am J Surg 211:84–88CrossRef
17.
Zurück zum Zitat de Giorgi V, Rossari S, Papi F, Gori A, Alfaioli B, Grazzini M et al (2010) Multiple primary melanoma: the impact of atypical naevi and follow up. Br J Dermatol 163:1319–1322CrossRef de Giorgi V, Rossari S, Papi F, Gori A, Alfaioli B, Grazzini M et al (2010) Multiple primary melanoma: the impact of atypical naevi and follow up. Br J Dermatol 163:1319–1322CrossRef
18.
Zurück zum Zitat Pastor-Tomás N, Martínez-Franco A, Bañuls J, Peñalver JC, Traves V, García-Casado Z et al (2020) Risk factors for the development of a second melanoma in patients with cutaneous melanoma. J Eur Acad Dermatol Venereol 34:2295–2302CrossRef Pastor-Tomás N, Martínez-Franco A, Bañuls J, Peñalver JC, Traves V, García-Casado Z et al (2020) Risk factors for the development of a second melanoma in patients with cutaneous melanoma. J Eur Acad Dermatol Venereol 34:2295–2302CrossRef
Metadaten
Titel
Predictors of subsequent primary melanoma: a case–control study
verfasst von
Francesco Bellinato
Paolo Rosina
Beatrice Tonin
Paolo Gisondi
Giampiero Girolomoni
Publikationsdatum
26.11.2021
Verlag
Springer Berlin Heidelberg
Erschienen in
Archives of Dermatological Research / Ausgabe 9/2022
Print ISSN: 0340-3696
Elektronische ISSN: 1432-069X
DOI
https://doi.org/10.1007/s00403-021-02309-9

Kompaktes Leitlinien-Wissen Dermatologie (Link öffnet in neuem Fenster)

Mit medbee Pocketcards schnell und sicher entscheiden.
Leitlinien-Wissen kostenlos und immer griffbereit auf ihrem Desktop, Handy oder Tablet.

Neu im Fachgebiet Dermatologie

Vorzeitiges Ergrauen der Haare: Kann es verhindert werden?

Das frühzeitige Ergrauen der Haare ist für viele Menschen eine Belastung. Es entsteht durch eine Kombination aus intrinsischen und extrinsischen Faktoren, wobei genetische Veranlagungen eine Schlüsselrolle spielen.

Verbände und Cremes gegen Dekubitus: „Wir wissen nicht, was sie bringen!“

Die Datenlage zur Wirksamkeit von Verbänden oder topischen Mitteln zur Prävention von Druckgeschwüren sei schlecht, so die Verfasser einer aktuellen Cochrane-Studie. Letztlich bleibe es unsicher, ob solche Maßnahmen den Betroffenen nutzen oder schaden.

Duale Checkpointhemmung gegen Melanome verlängert langfristig das Leben

Im Vergleich zu den Überlebenschancen vor der Einführung von Immuncheckpointhemmern (ICI) ist der Fortschritt durch eine ICI-Kombination mit unterschiedlichen Tagets bei fortgeschrittenem Melanom erstaunlich. Das belegen die finalen Ergebnisse der CheckMate-067-Studie und geben Betroffenen "Hoffnung auf Heilung".

Inzidenz und Mortalität von Melanomen sind gestiegen

Eine britische Arbeitsgruppe hat die Zahlen zu Inzidenz und Mortalität von kutanen Melanomen aus den Jahren 1990 bis 2019 in 19 Ländern mit hohem Einkommensniveau, darunter Deutschland, analysiert. Der Trend zeigt nach oben.

Update Dermatologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.